Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 331 | 130 | 37 | 84 | 99 |
| Cost of Goods | 139 | 55 | 15 | 28 | 34 |
| Gross Profit | 192 | 75 | 22 | 56 | 65 |
| Operating Expenses | -3,656 | -1,680 | -3,973 | -3,855 | -3,897 |
| Operating Income | 3,987 | 1,810 | 4,010 | 3,939 | 3,996 |
| Other Income | 26 | 25 | 29 | 24 | 27 |
| Pre-tax Income | 4,013 | 1,835 | 4,039 | 3,963 | 4,023 |
| Income Tax | N/A | 43 | 0 | -451 | -525 |
| Net Income Continuous | 4,013 | 1,792 | 4,039 | 4,414 | 4,548 |
| Net Income | $4,013 | $1,792 | $4,039 | $4,414 | $4,548 |
| EPS Basic Total Ops | 0.12 | 0.05 | 0.12 | 0.14 | 0.14 |
| EPS Basic Continuous Ops | 0.12 | 0.05 | 0.12 | 0.13 | 0.14 |
| EPS Diluted Total Ops | 0.12 | 0.05 | 0.12 | 0.14 | 0.14 |
| EPS Diluted Continuous Ops | 0.12 | 0.05 | 0.12 | 0.13 | 0.14 |
| EBITDA(a) | $4,172 | $1,996 | $4,199 | $4,128 | $4,184 |